Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

By News Health
1 month Ago

(MedPage Today) — SAN FRANCISCO — Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.
Median PFS improved from 10.7…

Source link : https://www.medpagetoday.com/meetingcoverage/ascogu/120094

Author :

Publish date : 2026-02-28 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Next-Gen Yellow Fever Vaccine Hits the Mark in Mid-Stage Trial

Supreme Court Birthright Citizenship Case Could Affect Newborns' Medicaid Status

Anti-CD38 Antibody Safe, Effective in Immune Thrombocytopenia

Low-Income Patients Benefit From Intensive Blood Pressure Management

Is Kissing for Celiacs Gluten-Free? Small Study Weighs In

As Opioid Use Declines, Gabapentinoid Co-Prescribing Rises